In addition, Cai et al. (41) demonstrated that PCP suppresses the production of inflammatory mediators by downregulating protein expression in the TLR4/NF-κB pathway, thereby reducing the generation and infiltration of inflammatory cells and subsequently alleviating inflammatory damage in lung tissue. This evidence concerns the gene TLR4 and pneumocystosis.